CANINE
AUTOIMMUNE THYROID DISEASE: COMMON PROBLEM OF PUREBRED DOGS
by W. Jean Dodds DVM (republished with permission from the author, ©
W. Jean Dodds DVM)
The information provided
here outlines an approach that has been used successfully by the author
to reduce the prevalence of clinically expressed canine thyroid disease
within susceptible families or breeds.
EARLY THYROID DISEASE
(THYROIDITIS)
COMPENSATORY AND CLINICAL CANINE HYPOTHYROIDISM
Most of the confusion
about the diagnosis and treatment of thyroid disease in purebred or mixed
breed dogs today stems from the expectation that affected animals must show
clinical signs of inadequate thyroid hormonal production (i.e. hypothyroidism)
in order to have the disease. The term hypothyroidism has been loosely applied
to describe all stages of this disease process whereas strictly speaking
it should be reserved for the end-stages when the animal's thyroid gland
is no longer capable of producing sufficient hormone(s) to sustain clinical
health. At this point, the dog can express any number of the non-specific
multisystem signs of thyroid dysfunction. But let's start at the beginning.
The most common cause
of canine thyroid disease is autoimmune thyroiditis (estimated 90% of cases).
Thyroiditis is an immune-mediated process that develops in genetically susceptible
individuals and is characterized by the presence of antithyroid antibodies
in the blood or tissues. Thyroiditis is believed to start in most cases
around puberty, and gradually progress through mid-life and old age to become
clinically expressed hypothyroidism once thyroid glandular reserve has been
depleted. During this process, the animal or person becomes more susceptible
to immune-mediated or other diseases affecting various target tissues and
organs. The prerequisite genetic basis for susceptibility to this disorder
has been in established in humans, dogs and several other species.
The above explanation
helps us to appreciate existing confusion and controversy within the veterinary
profession regarding whether or not testing or treatment is indicated for
dogs that fail to show typical signs of hypothyroidism. In fact, we have
only recently begun to recognize the subtle signs of early thyroid dysfunction
in dogs as prevalence of the autoimmune form of the condition has increased
within and among dog breeds. Today, some 50 breeds are genetically predisposed
to develop thyroid disease.
GENETIC SCREENING FOR THYROID DISEASE
These thyroid panels
and antibody tests can also be used for genetic screening of apparently
healthy animals to evaluate their fitness for breeding. A bitch with antithyroid
antibodies in her blood may pass these along to her puppies in her colostral
milk. Also, any dog having circulating antithyroid antibodies can eventually
develop clinical symptoms of thyroid or other autoimmune diseases.
Therefore, thyroid screening
can be very important for potential breeding stock.
Thyroid testing for genetic screening purposes is less likely to be meaningful
before puberty. Screening is initiated, therefore, once healthy dogs and
bitches have reached sexual maturity (between 10-14 months in males and
during the first anestrus period for females following their maiden heat).
Anestrus is a time when the female sexual cycle is quiescent, thereby removing
any influence of sex hormones on baseline thyroid function. This period
generally begins 12 weeks from the onset of the previous heat and lasts
one month or longer. The interpretation of results from baseline thyroid
profiles in intact females is more reliable when they are tested in anestrus.
Testing for health screening is performed at 12-16 weeks from the onset
of the previous heat. In fact, genetic screening of intact females for other
parameters like von Willebrand's disease or wellness health and reproductive
checkups should also be scheduled in anestrus females. Once the initial
thyroid profile is obtained, dogs and bitches should be rechecked on an
annual basis to assess their own health. Annual results permit comparisons
that should reveal early evidence of developing thyroid disease or dysfunction.
This also allows for early treatment where indicated to abort the development
or advancement of clinical signs associated with hypothyroidism.
Healthy young dogs (less
than 15-18 months of age) should have thyroid baseline levels for all parameters
in the upper 1/2 to 1/3 of the adult normal ranges. In fact, for optimum
thyroid function in screening breeding stock, levels should be at least
at the midpoint of the laboratory normal ranges, because lower levels may
well be indicative of the early stages of thyroiditis among relatives of
dog families known to have thyroid disease.
TREATMENT OF THYROID DISEASE
The new information
summarized here has changed our approach to treatment and control of thyroid
disease. In addition to providing thyroid supplementation for dogs showing
the typical signs of thyroid disease, we now know that treatment of dogs
showing the early stages of thyroiditis (based on the testing described
above) is necessary and important to correct the underlying thyroid imbalance,
reduce the risk of developing other related immune-mediated disorders, and
to control or prevent the process of thyroiditis from progressing to depletion
and exhaustion of the thyroid gland.
1. Type of Treatment
The treatment of choice
because of its wide safety margin and efficacy is T4 hormone (L - or levothyroxine).
The most commonly used brand names are Soloxine (Daniels) and Synthroid
(Flint) and we recommend either of these over generics especially for the
smaller breeds. Use of T3 hormone (triiodothyronine) is not recommended
for initial use because toxicity can more easily develop with this product;
T3 is the intercellular hormone whereas most of T4 must be first converted
to T3 before it achieves its metabolic effect. In some cases where the animal's
body cannot properly convert T4 to T3, the dog will need both T4 and T3
therapy to correct the problem. For this purpose, the general rule of thumb
is to give from 2/3 to a full dose of T4 and a 1/3 dosage of T3 (i.e.,
0.1 mg per 10-20 pounds of T4 plus 1 ugm per pound of T3 twice daily).
However, no dog should be treated with these thyroid hormonal preparations
without having proper veterinary testing, medical examination and follow-up.
2. Frequency of Treatment
Thyroid hormones should
always be given twice daily to effect the best response. Until recently,
veterinarians have been advised to give treatment to effect either once
or twice daily because data on this point was unclear. We now know
that the half-life of T4 in the dog is about 10-12 hours (much shorter than
humans); for T3, it's only 6-8 hours. Thus, about half of the hormone is
metabolized and excreted from the body within 12 hours. Furthermore,
twice daily dosing aids in controlling thyroiditis because it shuts off
pituitary production of TSH by negative feedback in concert with the half-life
of the hormone. In other words, the dog's own thyroid follicular cells become
quiescent and are less likely to stimulate production of the antithyroid
antibodies responsible for the disease. (Obviously these are simplistic
explanations of the complex metabolic, immunologic and biochemical events
involved.) Contrary to some popular wisdom, treatment with thyroid
hormone does not destroy or suppress the potential of the gland to respond
on its own once treatment is stopped for whatever reason. The latest veterinary
research shows that it takes the thyroid gland up to 30 days to recover
its full potential once therapy is withdrawn. Therefore if an animal has
been medicated, where the diagnosis is unclear, treatment should be withdrawn
(if it's clinically safe to do so) for 30 days before the animal is retested
with the complete type thyroid profile described above.
Follow-up testing after
initiating treatment is usually performed after four to eight weeks of therapy.
The sample should be taken 4-6 hours after the morning dosage and optimum
results will show thyroid values in the upper third of normal ranges at
the peak time of absorption. Dosage can then be adjusted accordingly if
needed. Dogs on long term therapy with thyroid hormones should be monitored
with complete panels (not just T4 as you need to be sure the dog's body
is converting the T4 medication properly to T3) on a regular basis (every
6-12 months).
CLINICAL SIGNS OF CANINE HYPOTHYROIDISM
Alterations in Cellular
Metabolism:
weakness / stiffness
/ laryngeal paralysis / facial paralysis / tragic expression / knuckling
or dragging feet / muscle wasting / megaesophagus / head tilt / drooping
eyelids
Neuromuscular Problems:
seizures / mental dullness
/ exercise intolerance / neurologic signs polyneuropathy / lethargy / weight
gain / cold intolerance / mood swings hyperexcitability / stunted growth
/ chronic infections
Dermatologic Diseases:
dry, scaly skin and
dandruff / coarse, dull coat / bilateral symmetrical hair loss / rat tail,
puppy coat / hyperpigmentation / seborrhea or greasy skin pyoderma or skin
infections / myxedema / chronic offensive skin odor
Reproductive Disorders:
infertility of either
sex / lack of libido / testicular atrophy / hypospermia aspermia / prolonged
interestrus interval / absence of heat cycles / silent heats / pseudopregnancy
/ weak, dying or stillborn pups
Cardiac Abnormalities:
slow heart rate (bradycardia)
/ cardiac arrhythmias / cardiomyopathys
Gastrointestinal
Disorders:
constipation / diarrhea
/ vomiting
Hematological Disorders:
bleeding / bone marrow
failure / low red blood cells / low white blood cells / low platelets
Ocular Diseases:
corneal lipid deposits
/ corneal ulceration / uveitis Keratococonjunctivitis / sicca or dry eye
/ infections of eyelid glands (Meibomian gland)
Other Associated
Disorders:
lgA deficiency / loss
of smell (dysosmia) / loss of taste / glycosuria / chronic active hepatitis
/ other endocrinopathies adrenal, pancreatic, parathyroid
PRINT THE FOLLOWING TWO FORMS AND TAKE
THEM TO YOUR VET IF YOU WOULD LIKE YOUR DOG TESTED FOR HYPOTHYROIDISM AND
HAVE THE RESULTS ANALYZED BY DR. W. JEAN DODDS DVM.
CLICK
HERE FOR TESTING INSTRUCTIONS
CLICK
HERE FOR TEST ORDER FORM